Stockscreener 앱 받기
1.60
20.40%
-0.41
시간 외 거래:
1.57
-0.03
-1.88%
전일 마감가:
$2.01
열려 있는:
$2
하루 거래량:
246.34K
Relative Volume:
2.41
시가총액:
$4.33M
수익:
$202.00K
순이익/손실:
$-28.96M
주가수익비율:
-2.6667
EPS:
-0.6
순현금흐름:
$-21.85M
1주 성능:
-37.01%
1개월 성능:
-39.39%
6개월 성능:
+1,586%
1년 성능:
+522.81%
1일 변동 폭
$1.56
$2.02
1주일 범위
$1.56
$2.62
52주 변동 폭
$0.0633
$20.35
AIM ImmunoTech Inc Stock (AIM) Company Profile
명칭
AIM ImmunoTech Inc
전화
352 448 7797
주소
2117 SW Highway 484, Ocala, FL
AIM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AIM
AIM ImmunoTech Inc
|
1.60 | 5.56M | 202.00K | -28.96M | -21.85M | -0.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
AIM ImmunoTech Inc 주식(AIM)의 최신 뉴스
AIM ImmunoTech to present phase 2 ovarian cancer study data at SITC - Investing.com
AIM ImmunoTech to present phase 2 ovarian cancer study data at SITC By Investing.com - Investing.com South Africa
AIM ImmunoTech Announces Late Breaking Abstract from University of Pittsburgh Medical Center Accepted for Presentation at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting - The Manila Times
AIM ImmunoTech Announces Late Breaking Abstract from - GlobeNewswire
Is AIM ImmunoTech Inc. (HXB) stock resilient in recession scenariosMarket Activity Recap & Precise Entry and Exit Recommendations - newser.com
Can AIM ImmunoTech Inc. stock expand revenue streamsTrade Risk Assessment & Consistent Income Trade Recommendations - newser.com
Is AIM ImmunoTech Inc. stock supported by strong fundamentals2025 Risk Factors & Low Risk High Reward Ideas - newser.com
Can AIM ImmunoTech Inc. (HXB) stock hit consensus price targets2025 Fundamental Recap & Fast Gain Swing Trade Alerts - newser.com
Is AIM ImmunoTech Inc. stock vulnerable to rate hikesMarket Volume Summary & Smart Investment Allocation Insights - newser.com
How forex fluctuations impact AIM ImmunoTech Inc. stockJuly 2025 Update & AI Optimized Trading Strategy Guides - newser.com
Why AIM ImmunoTech Inc. stock attracts HNW investorsInsider Selling & Weekly Return Optimization Plans - newser.com
How buyback programs support AIM ImmunoTech Inc. (HXB) stockQuarterly Risk Review & Weekly Top Gainers Alerts - newser.com
AIM ImmunoTech Announces European Patent Office Grants Patent Covering Ampligen® (Rintatolimod) for Use in the Treatment of the Post-COVID Condition of Fatigue - The Manila Times
AIM ImmunoTech Announces European Patent Office Grants - GlobeNewswire
AIM ImmunoTech (NYSE American: AIM) gains EU patent for Ampligen in post‑COVID fatigue - Stock Titan
What downside risks could hit AIM ImmunoTech Inc. (HXB) stockIndex Update & Low Risk High Reward Ideas - newser.com
How AIM ImmunoTech Inc. stock stacks up against competitors2025 Price Action Summary & Safe Entry Trade Reports - newser.com
Is AIM ImmunoTech Inc. stock dividend growth reliableNew Guidance & Verified Swing Trading Watchlist - newser.com
AIM ImmunoTech Inc (AIM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):